PCBP1

Across TCGA pan-cancer cohorts, PCBP1 mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of PCBP1’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where PCBP1 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types PCBP1 is over-expressed in tumor, although a few such as HNSC show the opposite, repressed pattern.

CCRCC, HNSC, and LSCC are the cancer types where PCBP1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in PCBP1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	Male	All	+0.118	<.001	7	view →
HNSC	All	All	−0.112	<.001	6	view →
LSCC	All	All	+0.063	.001	4	view →
COAD	All	All	+0.056	.013	3	view →
OV	All	All	+0.260	.007	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

PCBP1–CCRCC

Open the CCRCC breakdown →